Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | CANN GROUP LIMITED: Notification of cessation of securities - CAN | - | ASX | ||
CANN GROUP Aktie jetzt für 0€ handeln | |||||
Mi | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
Di | CANN GROUP LIMITED: Cann Settles Legal Dispute with Rua Biosciences | - | ASX | ||
Mo | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
Mo | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
30.05. | CANN GROUP LIMITED: Results of EGM | - | ASX | ||
30.05. | CANN GROUP LIMITED: CEO EGM Presentation | - | ASX | ||
20.05. | CANN GROUP LIMITED: Application for quotation of securities - CAN | 1 | ASX | ||
30.04. | CANN GROUP LIMITED: Application for quotation of securities - CAN | - | ASX | ||
30.04. | CANN GROUP LIMITED: Notice of Extraordinary General Meeting/Proxy Form | - | ASX | ||
30.04. | CANN GROUP LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
30.04. | CANN GROUP LIMITED: Tourette Syndrome Trial Outcomes | - | ASX | ||
28.04. | CANN GROUP LIMITED: Cann Group Receives $836k Funding Advance on R&D Refund | - | ASX | ||
14.04. | CANN GROUP LIMITED: Application for quotation of securities - CAN | 2 | ASX | ||
10.04. | CANN GROUP LIMITED: Proposed issue of securities - CAN | - | ASX | ||
10.04. | CANN GROUP LIMITED: Cleansing Prospectus | 2 | ASX | ||
09.04. | CANN GROUP LIMITED: Notification of cessation of securities - CAN | - | ASX | ||
08.04. | XFRA CVJ: WIEDERAUFNAHME/RESUMPTION | 156 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
08.04. | CANN GROUP LIMITED: Proposed issue of securities - CAN | - | ASX | ||
08.04. | CANN GROUP LIMITED: Cann Group Raises $712k via Private Placement | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 26,435 | +0,02 % | Bayer, Vidac Pharma, Evotec - schnappen Sie sich den 866 Milliarden Onkologie Jackpot | Die Onkologie erlebt eine beispiellose Revolution. Mit prognostizierten 866 Mrd. USD Marktvolumen bis 2034 und 11 % Jahreswachstum treiben KI-gestützte Diagnosen, personalisierte Gentherapien und Präzisionsmedizin... ► Artikel lesen | |
NOVO NORDISK | 65,55 | +2,49 % | SCHOCK bei Renk, Novo Nordisk Aktie "KAUFEN", PanGenomic Health auf den Spuren von Hims & Hers | Schock bei Renk & Co.! Gestern Nachmittag machte die Nachricht die Runde, dass die EU den Rüstungskonzernen an die Milliardengewinne gehen will. Schließlich stehen die Unternehmen vor goldenen Zeiten.... ► Artikel lesen | |
AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
ABBVIE | 166,40 | -0,12 % | AbbVie continues gains for seven straight sessions | ||
CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,357 | +0,11 % | Tilray Brands Inc: Tilray Brands to be deleted from S&P/TSX Composite | ||
VERTEX PHARMACEUTICALS | 395,50 | +0,08 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference | - Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT clarifies disclosure about Premium Products buy | ||
DERMAPHARM | 36,900 | -0,40 % | EQS-DD: Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.06.2025 / 11:18... ► Artikel lesen | |
CRONOS GROUP | 1,728 | -0,80 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
ORGANIGRAM GLOBAL | 1,170 | -1,68 % | Organigram Global Inc. reicht 6-K Bericht bei der SEC ein | ||
SNDL | 1,147 | -0,61 % | SNDL Inc.: SNDL Reports First Quarter 2025 Financial and Operational Results | The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure
EDMONTON, AB, May 1, 2025 ... ► Artikel lesen |